Nano Medicine

Cao W, Xia T. mRNA lipid nanoparticles induce immune tolerance to treat human diseases. Med Rev (Berl). 2023 Apr 14;3(2):180-183. doi: 10.1515/mr-2023-0008. PMID: 37724087; PMCID:[...]

By sjmartinez • September 19, 2023

Hicks MR, Liu X, Young CS, Saleh K, Ji Y, Jiang J, Emami MR, Mokhonova E, Spencer MJ, Meng H, Pyle AD. Nanoparticles systemically biodistribute[...]

By sjmartinez • August 31, 2023

Li J, Xiao Y, Zhang Y, Li S, Zhao M, Xia T, Meng H. Pulmonary Delivery of Specialized Pro-Resolving Mediators-Based Nanotherapeutics Attenuates Pulmonary Fibrosis in[...]

By sjmartinez • August 4, 2023

Luo L, Wang X, Liao YP, Chang CH, Nel AE. Correction to "Nanocarrier Co-formulation for Delivery of a TLR7 Agonist plus an Immunogenic Cell Death[...]

By sjmartinez • July 29, 2023

Xu X, Xia T. Recent Advances in Site-Specific Lipid Nanoparticles for mRNA Delivery. ACS Nanosci Au. 2023 Mar 30;3(3):192-203. doi: 10.1021/acsnanoscienceau.2c00062. PMID: 37360845; PMCID: PMC10288611.

By sjmartinez • June 27, 2023

Su Y, Zhou X, Meng H, Xia T, Liu H, Rolshausen P, Roper C, McLean JE, Zhang Y, Keller AA, Jassby D. Cost-benefit analysis of[...]

By sjmartinez • April 29, 2023

Chen YH, Nguyen D, Brindley S, Ma T, Xia T, Brune J, Brown JM, Tsai CS. The dependence of particle size on cell toxicity for[...]

By sjmartinez • March 30, 2023

Liu Q, Wang X, Liao YP, Chang CH, Li J, Xia T, Nel AE. Use of a Liver-targeting Nanoparticle Platform to Intervene in Peanut-induced anaphylaxis[...]

By sjmartinez • March 28, 2023

Goodman JE, Becich MJ, Bernstein DM, Case BW, Mandel JH, Nel AE, Nolan R, Odo NU, Smith SR, Taioli E, Gibbs G. Non-asbestiform elongate mineral[...]

By sjmartinez • March 26, 2023

Nel A. Carbon nanotube pathogenicity conforms to a unified theory for mesothelioma causation by pathogenic elongate materials and fibers. Environ Res. 2022 Nov 10:114580. doi:[...]

By sjmartinez • March 26, 2023